Skip to main content
Log in

Comparison of alternative βhCG follow-up protocols after single-dose methotrexate therapy for tubal ectopic pregnancy

  • General Gynecology
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the performances of five different βhCG follow-up protocols after single-dose methotrexate therapy for tubal ectopic pregnancy (EP).

Methods

Data of patients who received single-dose methotrexate therapy for tubal EP at a university hospital between January 2011 and July 2016 were reviewed. A ‘successful methotrexate treatment’ was defined if the EP treated with no need for surgery. The performances of different protocols were tested by comparing with the currently used ‘15% βhCG decrease between days 4 and 7’ protocol. The tested follow-up protocols were ‘20, 25%, and any βhCG decrease between days 0/1 and 7’ and ‘20% and any βhCG decrease between days 0/1 and 4’.

Results

Among the 96 patients evaluated, 12 (12.5%) required second dose. Totally, 91 (94.8%) patients treated successfully with no need for surgery. Four patients were operated within 4 days following the second dose. One patient who did not need second dose according to the standard follow-up protocol was operated on the 10th day due to rupture (specificity = 80%). Two protocols, namely ‘20% βhCG decrease between days 0/1 and 7’ and ‘any βhCG decrease between days 0/1 and 7’ did not show statistically significant differences from the index protocol regarding the number of patients who should be assigned to 2nd dose.

Conclusions

‘Any βhCG decrease between days 0/1 and 7’ protocol may substitute the currently used one to decide second dose methotrexate in tubal EP management. Omitting 4th day measurement seems to be more convenient and cost effective.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Hajenius PJ, Mol F, Mol BW et al (2007) Interventions for tubal ectopic pregnancy. Cochrane Database Syst Rev. doi:10.1002/14651858.CD000324.pub2

    PubMed  Google Scholar 

  2. Chang J, Elam-Evans LD, Berg CJ et al (2003) Pregnancy-related mortality surveillance—United States, 1991–1999. MMWR Surveill Summ 52:1–8

    PubMed  Google Scholar 

  3. Berg CJ, Callaghan WM, Henderson Z et al (2010) Pregnancy-related mortality in the United States, 1998 to 2005. Obstet Gynecol 116:1302–1309

    Article  PubMed  Google Scholar 

  4. Tanaka T, Hayashi H, Kutsuzawa T et al (1982) Treatment of interstitial ectopic pregnancy with methotrexate: report of a successful case. Fertil Steril 37:851–852

    Article  CAS  PubMed  Google Scholar 

  5. Stovall TG, Ling FW, Gray LA (1991) Single-dose methotrexate for treatment of ectopic pregnancy. Obstet Gynecol 77:754–757

    CAS  PubMed  Google Scholar 

  6. Kirk E, Condous G, Van Calster B et al (2007) A validation of the most commonly used protocol to predict the success of single-dose methotrexate in the treatment of ectopic pregnancy. Hum Reprod 22:858–863

    Article  CAS  PubMed  Google Scholar 

  7. Oron G, Tulandi T (2013) A pragmatic and evidence-based management of ectopic pregnancy. J Minim Invasive Gynecol 120:446–454

    Article  Google Scholar 

  8. Nguyen Q, Kapitz M, Downes K et al (2010) Are early human chorionic gonadotropin levels after methotrexate therapy a predictor of response in ectopic pregnancy? Am J Obstet Gynecol 202:630.e1–630.e5

    Article  Google Scholar 

  9. Skubisz M, Dutton P, Duncan WC et al (2010) Using a decline in serum hCG between days 0–4 to predict ectopic pregnancy treatment success after single-dose methotrexate: a retrospective cohort study. BMC Pregnancy Childbirth 13:30

    Article  Google Scholar 

  10. Atkinson M, Gupta S, McGee T (2014) βhCG monitoring after single-dose methotrexate treatment of tubal ectopic pregnancy: is the Day 4 βhCG necessary? A retrospective cohort study. Aust N Z J Obstet Gynaecol 54:475–479

    Article  PubMed  Google Scholar 

  11. Yildirim A, Akdag Cirik D, Altay M et al (2015) Early prediction for the requirement of second or third dose methotrexate in women with ectopic pregnancy, treated with single-dose regimen. Arch Gynecol Obstet 291:1327–1332

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

YES: Data management, Manuscript writing/editing. KK: Data collection, manuscript writing. MMS: Interpretation. EC: Interpretation. FD: Protocol/project development, Interpretation, Management.

Corresponding author

Correspondence to Yavuz Emre Şükür.

Ethics declarations

Conflict of interest statement

The authors of this article report no conflict of interest.

Ethical approval

All procedures performed were in accordance with the ethical standards of the institutional review board and with the Helsinki Declaration or comparable ethical standards.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Şükür, Y.E., Koyuncu, K., Seval, M.M. et al. Comparison of alternative βhCG follow-up protocols after single-dose methotrexate therapy for tubal ectopic pregnancy. Arch Gynecol Obstet 296, 1161–1165 (2017). https://doi.org/10.1007/s00404-017-4527-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-017-4527-1

Keywords

Navigation